Looking $100 million
CEO Dr. Liat Goldshaid-Zmiri describes how a casual e-mail led to aesthetic medicine company Luminera's acquisition by AbbVie.
AI in the kitchen
Founder Gil Kerbs tells "Globes" about Newt and its personalized nutrition app, which provides motivation as well as menus.
Teva at the double
Good results, falling debt and Covid-19 have all contributed to the Israeli drugmaker's share price nearly doubling since March.